The funds raised will be used by the company for its next phase of growth Going forward, Boca Biolistics will be led by two of its founders, CEO Valentin Adia and COO Michael Morris, both of whom have ...
TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) (“CVG”) today announced that it, together with Clairvest Equity Partners VI (“CEP VI”, collectively “Clairvest”) has made a ...
OXFORD, England--(BUSINESS WIRE)--Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing personalized medicine tests based on 3D genomics, has entered into a strategic ...
DALLAS--(BUSINESS WIRE)--Generational Equity, a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the investment in its client, Boca Biolistics (Boca) by ...
Partnership aims to advance disease severity testing programme for COVID-19 Oxford BioDynamics has entered a strategic partnership with US-based biorepository, reference lab and contract research ...
Biolistics is a method for the delivery of nucleic acid to cells by high-speed particle bombardment. The technique uses nucleic acid-coated particles propelled by a pressurized gun (gene gun) to ...
TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) (“CVG”) today announced that it, together with Clairvest Equity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results